Two parties often don't see the same picture the same way. We help clients understand payers' interests and concerns, which helps with structuring and presenting deals – saving time and accelerating listing solutions.
To fund tomorrow's medical advances, our clients need to maintain buoyant list prices for today's products. Our expertise in structuring creative product listing agreements help clients do just that.
Clients benefit from our insights into public payers' interests and concerns. We help clients to develop and critically assess market access options, enabling more thoughtful decisions.
We help pharmaceutical companies and governments to leverage their common interests, the most important being their shared desire to help patients become well. We help find commercially practical ways to align their other interests.
There are no maps to guide those seeking public reimbursement for new health technologies. We help clients to navigate through the public reimbursement environment.
Pathway Advisory Services serves leading and emerging pharmaceutical companies, medical device manufacturers and governments in the constantly changing environment that is market access. For our private sector clients, we help to develop, evaluate and execute market access strategies. Our approach uses our insights into how public payers think to help our clients to structure reimbursement arrangements that serve both parties well.
The concept of a national or interprovincial formulary has been debated by policy makers for many decades now. While significant progress has remained...
Over the past five years, product listing agreements (also known as Industry-Payor Agreements) have been increasingly accepted as a way for manufacturers to gain public...
Gaining public and private reimbursement for a pharmaceutical product or medical device is a critical milestone for our clients.